Labshake search
Citations for Phoenix Pharmaceuticals :
1 - 6 of 6 citations for Scyliorhinin II amide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... GLP-1 (7-36)-amide (Phoenix Pharmaceuticals), CCK-8 (PolyPeptides Laboratories) ...
-
bioRxiv - Cell Biology 2022Quote: ... Ang II (Phoenix Pharmaceuticals) was infused via subcutaneously implanted osmotic minipump (ALZET model 1007D ...
-
bioRxiv - Neuroscience 2022Quote: MT-II (Phoenix Pharmaceuticals, Burlingame, CA) was reconstituted in sterile saline in a stock solution at a concentration of 10 nmol/ul and stored at -20 C ...
-
bioRxiv - Neuroscience 2020Quote: ... the α-MSH analog melanotan II (MTII, Phoenix Pharmaceuticals, USA) was dissolved in phosphate-buffered saline (PBS) ...
-
bioRxiv - Physiology 2021Quote: ... Angiotensin II (AngII, 800ng/kg, EK-002-12CE, Phoenix Pharmaceuticals, Burlingame, CA), Furosemide (Furo 1mg/kg ...
-
bioRxiv - Genetics 2020Quote: ... Wild-type and mutant MC4Rs functionality was tested in HEK293T cells by means of MC4R agonist-evoked activation of inhibitory currents on type 2.2 voltage-gated calcium channels (CaV2.2) after bath application of the MC4/MC3 agonist melanotan II (MTII, Phoenix Pharmaceutical), as previously described [24] ...